Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5 Cutcombe Road, London, SE5 9RX, UK.
Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, Cáceres, Spain.
Cell Mol Life Sci. 2024 Jul 15;81(1):304. doi: 10.1007/s00018-024-05337-6.
The autophagy-lysosomal pathway plays a critical role in the clearance of tau protein aggregates that deposit in the brain in tauopathies, and defects in this system are associated with disease pathogenesis. Here, we report that expression of Tau35, a tauopathy-associated carboxy-terminal fragment of tau, leads to lipid accumulation in cell lines and primary cortical neurons. Our findings suggest that this is likely due to a deleterious block of autophagic clearance and lysosomal degradative capacity by Tau35. Notably, upon induction of autophagy by Torin 1, Tau35 inhibited nuclear translocation of transcription factor EB (TFEB), a key regulator of lysosomal biogenesis. Both cell lines and primary cortical neurons expressing Tau35 also exhibited changes in endosomal protein expression. These findings implicate autophagic and endolysosomal dysfunction as key pathological mechanisms through which disease-associated tau fragments could lead to the development and progression of tauopathy.
自噬溶酶体途径在清除tau 蛋白聚集体中起着关键作用,tau 蛋白聚集体在神经退行性tau 病中沉积在大脑中,而该系统的缺陷与疾病发病机制有关。在这里,我们报告说,tau 病相关的 tau 羧基末端片段 Tau35 的表达导致细胞系和原代皮质神经元中的脂质积累。我们的研究结果表明,这可能是由于 Tau35 对自噬清除和溶酶体降解能力的有害阻断。值得注意的是,在 Torin 1 诱导自噬后,Tau35 抑制了转录因子 EB(TFEB)的核易位,TFEB 是溶酶体生物发生的关键调节因子。表达 Tau35 的细胞系和原代皮质神经元也表现出内体蛋白表达的变化。这些发现表明自噬和内溶酶体功能障碍是疾病相关 tau 片段导致 tau 病发展和进展的关键病理机制。